The November Newsletter is now available. You can see this and past newsletters in the DIDB Resource Center. Please note that you must be signed in to access.
Also available in the Resource Center under “DIDB Team’s Communication” are the two posters presented at the last ISSX meeting in Orlando:
- SYSTEMATIC REVIEW OF THE QUANTITATIVE DRUG EXPOSURE DATA AVAILABLE IN THE PHARMACOGENETIC LITERATURE USING THE UNIVERSITY OF WASHINGTON E-PKGENE© APPLICATION IDENTIFIES DRUGS MOST SENSITIVE TO GENETIC VARIATIONS (Sophie Argon, Todd M Smith, Zhu Zhou, Isabelle Ragueneau-Majlessi).
- WHAT CAN BE LEARNED FROM THE NDA AND BLA REVIEWS OF NEWLY APPROVED DRUGS? A SYSTEMIC REVIEW OF DRUG INTERACTION DATA FOR DRUGS APPROVED BY THE US FDA IN 2014 (Jingjing Yu, Tasha K. Ritchie, Zhu Zhou, Isabelle Ragueneau-Majlessi).
Do not hesitate to contact us with comments or suggestions.